Peritoneal dialysis in the management of severe hypercalcaemia

P. J. Heyburn, P. L. Selby, Munro Peacock, L. R. Sandler, F. M. Parsons

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Severe hypercalcaemia often presents as an acute emergency without an obvious cause. Initial management aims to lower plasma calcium until the cause of the hypercalcaemia is established. Renal failure is usually present, and treatment by peritoneal dialysis to reduce plasma calcium and to improve uraemia has obvious advantages over present standard treatments. Nevertheless, its use has not become established since most commercially prepared dialysis fluids contain calcium. Travenol Laboratories have recently produced a 3-1 parenteral infusion container into which solutions of any composition can be introduced. We have used it for peritoneal dialysis with calcium-free dialysate in a patient with severe resorptive hypercalcaemia. Our biochemical methods have been described.

Original languageEnglish (US)
Pages (from-to)525-526
Number of pages2
JournalBMJ (Clinical research ed.)
Volume280
Issue number6213
StatePublished - 1980
Externally publishedYes

Fingerprint

Hypercalcemia
Peritoneal Dialysis
Calcium
Parenteral Infusions
Uremia
Dialysis Solutions
Renal Insufficiency
Dialysis
Emergencies
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Heyburn, P. J., Selby, P. L., Peacock, M., Sandler, L. R., & Parsons, F. M. (1980). Peritoneal dialysis in the management of severe hypercalcaemia. BMJ (Clinical research ed.), 280(6213), 525-526.

Peritoneal dialysis in the management of severe hypercalcaemia. / Heyburn, P. J.; Selby, P. L.; Peacock, Munro; Sandler, L. R.; Parsons, F. M.

In: BMJ (Clinical research ed.), Vol. 280, No. 6213, 1980, p. 525-526.

Research output: Contribution to journalArticle

Heyburn, PJ, Selby, PL, Peacock, M, Sandler, LR & Parsons, FM 1980, 'Peritoneal dialysis in the management of severe hypercalcaemia', BMJ (Clinical research ed.), vol. 280, no. 6213, pp. 525-526.
Heyburn PJ, Selby PL, Peacock M, Sandler LR, Parsons FM. Peritoneal dialysis in the management of severe hypercalcaemia. BMJ (Clinical research ed.). 1980;280(6213):525-526.
Heyburn, P. J. ; Selby, P. L. ; Peacock, Munro ; Sandler, L. R. ; Parsons, F. M. / Peritoneal dialysis in the management of severe hypercalcaemia. In: BMJ (Clinical research ed.). 1980 ; Vol. 280, No. 6213. pp. 525-526.
@article{4d14b90751a1478e9d8d6e591406e5f3,
title = "Peritoneal dialysis in the management of severe hypercalcaemia",
abstract = "Severe hypercalcaemia often presents as an acute emergency without an obvious cause. Initial management aims to lower plasma calcium until the cause of the hypercalcaemia is established. Renal failure is usually present, and treatment by peritoneal dialysis to reduce plasma calcium and to improve uraemia has obvious advantages over present standard treatments. Nevertheless, its use has not become established since most commercially prepared dialysis fluids contain calcium. Travenol Laboratories have recently produced a 3-1 parenteral infusion container into which solutions of any composition can be introduced. We have used it for peritoneal dialysis with calcium-free dialysate in a patient with severe resorptive hypercalcaemia. Our biochemical methods have been described.",
author = "Heyburn, {P. J.} and Selby, {P. L.} and Munro Peacock and Sandler, {L. R.} and Parsons, {F. M.}",
year = "1980",
language = "English (US)",
volume = "280",
pages = "525--526",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "6213",

}

TY - JOUR

T1 - Peritoneal dialysis in the management of severe hypercalcaemia

AU - Heyburn, P. J.

AU - Selby, P. L.

AU - Peacock, Munro

AU - Sandler, L. R.

AU - Parsons, F. M.

PY - 1980

Y1 - 1980

N2 - Severe hypercalcaemia often presents as an acute emergency without an obvious cause. Initial management aims to lower plasma calcium until the cause of the hypercalcaemia is established. Renal failure is usually present, and treatment by peritoneal dialysis to reduce plasma calcium and to improve uraemia has obvious advantages over present standard treatments. Nevertheless, its use has not become established since most commercially prepared dialysis fluids contain calcium. Travenol Laboratories have recently produced a 3-1 parenteral infusion container into which solutions of any composition can be introduced. We have used it for peritoneal dialysis with calcium-free dialysate in a patient with severe resorptive hypercalcaemia. Our biochemical methods have been described.

AB - Severe hypercalcaemia often presents as an acute emergency without an obvious cause. Initial management aims to lower plasma calcium until the cause of the hypercalcaemia is established. Renal failure is usually present, and treatment by peritoneal dialysis to reduce plasma calcium and to improve uraemia has obvious advantages over present standard treatments. Nevertheless, its use has not become established since most commercially prepared dialysis fluids contain calcium. Travenol Laboratories have recently produced a 3-1 parenteral infusion container into which solutions of any composition can be introduced. We have used it for peritoneal dialysis with calcium-free dialysate in a patient with severe resorptive hypercalcaemia. Our biochemical methods have been described.

UR - http://www.scopus.com/inward/record.url?scp=0018874074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018874074&partnerID=8YFLogxK

M3 - Article

VL - 280

SP - 525

EP - 526

JO - The BMJ

JF - The BMJ

SN - 0959-8146

IS - 6213

ER -